Kyverna Therapeutics, Inc. Quarterly Interest Expense in USD from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Kyverna Therapeutics, Inc. quarterly Interest Expense history and growth rate from Q1 2023 to Q2 2024.
  • Kyverna Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $39K, a 15.2% decline year-over-year.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $39K -$7K -15.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $44K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q2 2023 $46K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $44K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.